Skip to content

Investigation of U1-A Uterine Anomalies Implantation Markers From the Lateral Walls of the Endometrium

Investigation of Implantation Markers of Anomalies Classified as U1-A Uterine According to ESHRE/ESGE Classification of Female Genital Tractus Anomalies in Biopsy Specimens Obtained From the Lateral Walls of the Endometrium

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04501003
Enrollment
35
Registered
2020-08-06
Start date
2019-12-12
Completion date
2021-05-31
Last updated
2020-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genital Tract Anomalies, Infertility, Female, T-Shaped Uterus

Keywords

T-Shaped Uterus, Infertility, Female, Intregrin Beta 3, Genital Tract Anomalies

Brief summary

Various types and classes of uterine malformations have been identified and the ESHRE / ESGE classification system has recently been published on female genital system anomalies. Postoperative positive pregnancy results were obtained in studies conducted in patients with infertility, recurrent implantation failure, and recurrent pregnancy loss, which were not previously described in T-shaped uterine anomalies. Considering the increase in endometrial gland and vascularity after the surgical procedure performed in these patients, our primary goal in our study is to compare the number of implantation markers (αVβ3 integrin) and subepithelial glands in the specimen biopsies taken from the lateral walls of the endometrium before and after hysteroscopic surgery in patients with class U1a anomalies.

Interventions

DEVICEBipolar cutting electrode (26040 BL1 Karl Storz, Tuttlingen)

With the bipolar cutting electrode (26040 BL1 Karl Storz, Tuttlingen. Germany), a single incision was made from the bottom of the ostium onto the lateral walls up to the isthmus, with both lateral horns perpendicular to myometrium. The depth of the incision was between 5 and 7 mm. The cavity was widened to be triangular and symmetrical. Both tubal ostium surgeries were clearly observed at the end of the surgery. All patients were discharged on the day of surgery and no hormonal therapy and intrauterine balloon was applied after surgery. Approximately 3 months after the hysteroscopic T-shaped operation, an office hysteroscopy operation was planned to control patients in the secretory phase, to perform uterine cavity and post-operative fly control and to receive post-operative control endometrial biopsy specimens.

Sponsors

Ufuk University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1. 18-45 age, 2. Have no systemic disease, 3. ESGE U1-A having uterine anomaly, 4. Primary infertile, recurrent implantation loss, recurrent pregnancy loss history, 5. Not having previous uterine surgery.

Exclusion criteria

1. Patients over the age of 45 under the age of 18, 2. Those with systemic disease (Hypertension, Heart Disease, Asthma, Renal Disease, Liver Disease, Epilepsy), 3. Having previous uterine surgery, 4. Those who gave birth.

Design outcomes

Primary

MeasureTime frameDescription
Comparison of endometrial lateral wall biopsies before and after hysteroscopic metroplasty in patients with T-shaped uterus.BaselineFrom the endometrium biopsies taken before and after the operation, the implantation marker beta 3 integrin was examined to determine if there was any change in the implantation.

Countries

Turkey (Türkiye)

Contacts

Primary ContactSezin Oral Yıldız, M.D.
drsezinoral@gmail.com+905374459898

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026